Dr. Michelle Sagaert
0749.865.230 · rovalta.com · 25/09/2026
Dr. Michelle Sagaert
Financial year 2025 · Closed on 30/09/2025
Overview
Identity
Source · BCE/KBODr. Michelle Sagaert is a Private limited company incorporated in 2020. Its main activity is: General medical practice activities. Its registered office is in Tielt.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0749.865.230
- Incorporation
- 06/07/2020
- Legal form
- Private limited company
- Registered office
- Leopold Sacrezstraat 46
8760 Tielt · FlandreSee on map - Contributed capital
- 1 000,00 €
- Latest accounts
- 30/09/2025
Financials
Source · NBB, 5 filingsTrend over 5 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 21,8 k € | -79.7% | 107,3 k € | +71.5% | 62,6 k € | -28.5% | 87,5 k € | +32.9% | 65,9 k € |
| EBITDA | 21,7 k € | -79.8% | 107,2 k € | +71.6% | 62,5 k € | -28.6% | 87,4 k € | +32.7% | 65,9 k € |
| Operating result | 13,2 k € | -86.7% | 99,3 k € | +80.3% | 55,1 k € | -35.4% | 85,2 k € | +29.9% | 65,6 k € |
| Net result | 11,1 k € | -85.4% | 75,7 k € | +74.0% | 43,5 k € | -35.8% | 67,8 k € | +32.4% | 51,2 k € |
| Balance sheet | |||||||||
| Equity | 12,1 k € | -84.3% | 76,7 k € | -53.1% | 163,5 k € | +36.3% | 120 k € | +130% | 52,2 k € |
| Total assets | 263,3 k € | +39.4% | 188,8 k € | +6.3% | 177,7 k € | +21.7% | 146 k € | +93.3% | 75,5 k € |
| Cash | 10,4 k € | -86.6% | 77,5 k € | +35.7% | 57,1 k € | +45.6% | 39,2 k € | -39.0% | 64,3 k € |
| Debts | 249,2 k € | +133% | 106,9 k € | +755% | 12,5 k € | -49.1% | 24,6 k € | +12.2% | 21,9 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 30/09/20251 active · 1 ended
Active mandates
Ended mandates
Other companies at this address
Leopold Sacrezstraat 46 8760 Tielt| Company | CBE no. |
|---|---|
Dr. Maxim Demeulenaere● Active | 0749.865.725 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/10/2024 | 01/10/2023 | 01/10/2022 | 01/10/2021 | 07/07/2020 |
| Closing of the financial year | 30/09/2025 | 30/09/2024 | 30/09/2023 | 30/09/2022 | 30/09/2021 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 15 months |
| Filing date | 09/01/2026 | 24/03/2025 | 22/03/2024 | 20/03/2023 | 06/04/2022 |
| General meeting | 15/12/2025 | 21/03/2025 | 15/03/2024 | 17/03/2023 | 18/03/2022 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 5 filingsValuation
Indicative valuation
As an indication, this company is worth
between 250 k€ and 500 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/09/20251 active · 1 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202511,1 k €↓
- 2024Annual accounts 202475,7 k €↑
- 2023Annual accounts 202343,5 k €↓
- 2022Annual accounts 202267,8 k €↑
- 2021Annual accounts 202151,2 k €
- 06/07/2020IncorporationPrivate limited company